|
||||
| Sunday, October 21, 2007: 6:30 PM-8:30 PM | |||
| Grand Station III, IV, V (Sheraton Station Square Hotel) | |||
| Poster Session I | |||
| P1-1 | QUANTIFYING THE EFFECTS OF DOUBLE COUNTING MORTALITY IN MODELING: DOES IT MATTER? Jesse D. Ortendahl, BS, Jeremy D. Goldhaber-Fiebert, AB, Natasha K. Stout, Ph.D. | ||
| P1-2 | BAYESIAN APPROACHES TO THE META-ANALYSIS OF DIAGNOSTIC TESTS: A COMPARATIVE STUDY OF BIVARIATE BINOMIAL AND MULTINOMIAL MODELS Yan Xing, MD, MS, Asha S. Kapadia, PhD, Janice N. Cormier, MD, MPH, John M. Swint, PhD, Claudia Pedroza, PhD | ||
| P1-3 | PATIENT PREFERENCES FOR DRUG TREATEMENTS FOR PSORIASIS: A DISCRETE CHOICE EXPERIMENT Darren M. Ashcroft, PhD, Elizabeth M. Seston, PhD, Christopher EM Griffiths, MD | ||
| P1-4 | THE COST-EFFECTIVENESS OF THROMBOPHILIA TESTING IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM Matt Stevenson, PhD, Emma L. Simpson, PhD, Andrew C. Rawdin, MSc, Diana Papaioannou, MSc | ||
| P1-5 | COST-EFFECTIVENESS OF HIV SCREENING IN PRISONS Arielle Lasry, PhD, Stephanie Sansom, PhD, Ram K. Shrestha, PhD, Krishna Jafa-Bhushan, MBBS, Jennifer Taussig, MPH, Anne C. Spaulding, MD, MPH | ||
| P1-6 | *OVER-THE-COUNTER AVAILABILITY OF PLAN B ON TEENS CONTRACEPTIVE DECISION MAKING Tamar P. Krishnamurti, MS, Sara L. Eggers, PhD, Baruch Fischhoff, PhD | ||
| P1-7 | *AN INFORMATION VISUALIZATION APPROACH TO CLASSIFICATION AND ASSESSMENT OF DIABETES RISK Christopher A. Harle, MS, Rema Padman, PhD, Daniel B. Neill, PhD | ||
| P1-8 | TRANSITION PROBABILITIES FOR COMBINATION USE OF ANTIHYPERTENSIVE AND LIPID-LOWERING MEDICATIONS IN A CALIFORNIA MEDICAID HYPERTENSIVE POPULATION Michael B. Nichol, PhD, Tara K. Knight, PhD, Joanne Wu, MS, Simon SK Tang, MPH, Spencer B. Cherry, BA, Joshua S. Benner, PhD | ||
| P1-9 | USING FRAILTY MODELS TO ASSESS THE EFFECT OF UNOBSERVED HETEROGENEITY ON THE COST-EFFECTIVENESS OF CARDIOVASCULAR DISEASE PREVENTION STRATEGIES H. Koffijberg, Erik Buskens, PhD, Ben van Hout, PhD | ||
| P1-10 | THE IMPACT OF A CONSUMER-DIRECTED HEALTH PLAN ON PATIENT OUTCOMES IN A LARGE NATIONAL EMPLOYER'S DIABETES POPULATION Michael B. Nichol, PhD, Tara K. Knight, PhD, Joanne Wu, MS, Thomas Parry, PhD, Dennis H. Honda | ||
| P1-11 | *A COST-EFFECTIVENESS ANALYSIS OF HEPATITIS C SCREENING AMONG IMMIGRANTS IN CANADA Wendong Chen, MD, Katherine Dinner, Tom Wong, Jenny Heathcote, MD, Murray D. Krahn, MD, MSc | ||
| P1-12 | *THE INFLUENCE OF IDEAL AFFECT ON HEALTHCARE PREFERENCES Tamara L. Sims, MA, Jeanne L. Tsai, PhD | ||
| P1-13 | *THE NATURAL HISTORY OF HEPATITIS C INFECTION ACQUIRED THROUGH INJECTION DRUG USE: A BAYESIAN META-ANALYSIS Ava John-Baptiste, MHSc, Murray D. Krahn, MD, MSc, George Tomlinson, PhD | ||
| P1-14 | “IT'S NOT LIKE I CAN CHANGE MY MIND LATER”: REVERSIBILITY IN PROSTATE CANCER TREATMENT DECISION-MAKING Nora B. Henrikson, MPH, Donna L. Berry, PhD | ||
| P1-15 | RESULTS FROM AN INTERNET PREFERENCE ELICITATION PANEL OF MEMBERS OF THE GENERAL PUBLIC Ken Stein, MB, ChB, MSc, FF, Ruairidh Milne, BA, MB, ChB, MSc, Tania Crabb, BSc, Matthew Dyer, MB, BS, Julie Ratcliffe, PhD, John Brazier, PhD | ||
| P1-16 | *IS THERE A ROLE FOR A DECISION AID IN FAMILIAL ADENOMATOUS POLYPOSIS? Heather B. Neuman, MD, Mary E. Charlson, MD, Larissa KF Temple, MD | ||
| P1-17 | HAVE YOUR CAKE OR EAT IT: DO DECISIONS BASED ON COST-EFFECTIVENESS UNDERMINE INCENTIVES FOR RESEARCH AND DEVELOPMENT? Karl Claxton, PhD, MSc, BA | ||
| P1-18 | CLINICAL AND DEMOGRAPHIC PREDICTORS OF UTILITY AND QUALITY OF LIFE IN PROSTATE CANCER SURVIVORS Karen E. Bremner, BSc, Matthew E. Kowgier, MSc, Shabbir M. H. Alibhai, MD, MSc, Gary Naglie, MD, Audrey Laporte, PhD, Murray D. Krahn, MD, MSc | ||
| P1-19 | THREE SCIENTIFIC PARADIGMS IN HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCES OF THE COMMITTEE TO EVALUATE DRUGS IN ONTARIO, CANADA Murray D. Krahn, MD, MSc, Chaim Bell, MD, PhD, Scott Berry, MD, MSc, Bill Evans, MD, Kelly Zarnke, MD, Nancy Lum-Wilson, BScPharm, MBA | ||
| P1-20 | A MODULAR OPEN-FORMAT DECISION MODEL REPRESENTATION AND PRESENTATION METHODOLOGY C. Greg Hagerty, PhD, Frank A. Sonnenberg, MD | ||
| P1-21 | UNDERSTANDING INDIVIDUAL QUALITY OF LIFE INDICATORS TO IMPROVE CARE FOR PERSONS WITH CHRONIC MENTAL ILLNESS Martha Shumway, PhD, Melissa Moore, PhD, Jennifer Alvidrez, Ph.D. | ||
| P1-22 | *PATIENT VS. SOCIETY - THOMAS SCHELLING'S TIPPING POINT Matan J. Cohen, MD, MPH, Moshe Leshno, Mayer Brezis, MD, MPH | ||
| P1-23 | EXPECTED VALUE OF RESEARCH ON COMPARATIVE COST-EFFECTIVENESS OF ANTIPSYCHOTIC MEDICATIONS David O. Meltzer, MD, PhD, Anirban Basu, PhD, Herbert Meltzer, MD | ||
| P1-24 | WEIGHING HARM IN THERAPEUTIC DECISIONS IN PULMONARY TUBERCULOSIS. A MULTICOUNTRY SURVEY Juan Moreira, MD, Bettina Bisig, MD, Petronille Muwawenimana, MD, Paulin Basinga, MD, Zeno Bisoffi, Md, Frank Haegeman, MD, Panduru Kishore, MD, Jef Van den Ende, PhD | ||
| P1-25 | MODELING THE POTENTIAL COST-EFFECTIVENESS OF ADDING A NOVEL STAT-C AGENT TO CURRENT STANDARD THERAPY IN PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION Gillian D. Sanders, PhD, Sam P. Galhenage, MD, Keyur Patel, MD, Kevin A. Schulman, MD, John G. McHutchison, MD | ||
| P1-26 | *CONCURRENT CHEMOTHERAPY AND HOSPICE: ONE SOLUTION TO HOSPICE UNDERUSE AMONG PATIENTS WITH ADVANCED LUNG CANCER Talya Salz, BS, Noel T. Brewer, PhD | ||
| P1-27 | PHARMACIST-PROVIDED SERVICE TO REDUCE THE RISK OF MEDICATION RELATED PROBLEMS: A CONTINGENT VALUATION STUDY Grainne E. Crealey, PhD, James C. McElnay, PhD, Motasim Badri, PhD | ||
| P1-28 | USING ICON ARRAYS TO COMMUNICATE RISK REDUCTION Mirta Galesic, PhD, Rocio Garcia-Retamero, PhD, Gerd Gigerenzer, PhD | ||
| P1-29 | PREDICTING EQ-5D-US HEALTH STATE VALUES FROM THE OSTEOPOROSIS ASSESSMENT QUESTIONNAIRE Christine M. McDonough, PT, PhD, Amber D. Elledge, MS, Margaret R. Grove, MS, Anna N.A. Tosteson, ScD | ||
| P1-30 | *EXAMINING THE TAIL OF THE CURVE: A COMPARISON OF METHODS FOR MODELING ADJUVANT CHEMOTHERAPY FOR STAGE III COLORECTAL CANCER Zhiying Zhao, BA, Deborah Schrag, MD, MPH, Karen M. Kuntz, ScD | ||
| P1-31 | INABILITY TO INDUCE ADAPTATION IN UTILITIES FOR HYPOTHETICAL HEALTH STATES: THE EFFECT OF TIME OF ONSET OF DISEASE ON STANDARD GAMBLES Eve Wittenberg, PhD | ||
| P1-32 | TIME COSTS AND OUT-OF-POCKET COSTS OF PROSTATE CANCER SURVIVORS IN ONTARIO, CANADA Steven M. Carcone, MSc, Karen E. Bremner, BSc, Matthew E. Kowgier, MSc, Murray D. Krahn, MD, MSc | ||
| P1-33 | DIABETES CARE MANAGEMENT THROUGH COPAY WAIVERS: A CASE STUDY A.C. Honish, MS, C.H. Amidon, Pharm.D., A.J. Ashby, MS, B. Franklin-Thompson, Pharm.D., S. Momin, MS, MBA | ||
| P1-34 | CALIBRATION METHODS USED IN CANCER SCREENING MODELS Natasha K. Stout, Ph.D., Pamela M. McMahon, Ph.D., Amy B. Knudsen, Ph.D., Chung Yin Kong, Ph.D., G. Scott Gazelle, MD, MPH, PhD | ||
| P1-35 | *BENEFITS OF DECREASED TIME TO TREATMENT ENTRY FOR PATIENTS WITH PANIC DISORDER Chara E. Rydzak, BA, Jane J. Kim, PhD | ||
| P1-36 | ARE WE ADEQUATELY INFORMING OUR PATIENTS? PROVIDERS' PERSPECTIVES ACROSS 14 COMMON DECISIONS Ekeoma Uzogara, BS, Carrie A. Levin, PhD, Karen R. Sepucha, PhD | ||
| P1-37 | VETERANS' INFORMATION PREFERENCES AND PERCEIVED INFORMATION EXCHANGE IN CHRONIC HEART FAILURE CARE Cathleen J. Appelt, PhD, Keri L. Rodriguez, PhD, Galen E. Switzer, PhD, James F. Luther, MA, Ali F. Sonel, MD, Robert M. Arnold, MD | ||
| P1-38 | DERIVATION OF LIFE TABLES BY SMOKING AND OBESITY AND THEIR UTILITY IN PUBLIC HEALTH POLICY MODELS Y. Claire Wang, MD, ScD, Barry I. Graubard, PhD, Karen M. Kuntz, ScD, Marjorie A. Rosenberg, PhD, Katherine M. Flegal, PhD, Eric J. Feuer, PhD | ||
| P1-39 | RELATIONSHIPS AMONG PERCEIVED RISK OF MORTALITY, COMORBIDITY-BASED PROGNOSIS, AND END-OF-LIFE CHOICES AMONG AFRICAN AMERICANS WITH END-STAGE RENAL DISEASE Anne-Marie Shields, BA, Mandy B. Holbrook, BA, Jennifer S. Prince, Heidi S. Donovan, PhD, Mi-Kyung Song, PhD | ||
| P1-40 | *DECISION AID FOR BREAST CANCER RISK CALCULATION USING BAYESIAN NETWORKS Luis J. Novoa, MSc, Carolina Barrios, PhD, Mario J. Castillo, MSc, Fabio Torres, MD | ||
| P1-41 | *THE COST-EFFECTIVENESS OF GENERAL VERSUS TARGETED HIV VACCINATION STRATEGIES IN THE U.S Elisa F. Long, MS, Margaret L. Brandeau, PhD, Douglas K. Owens, MD, MS | ||
| P1-42 | AGE-SPECIFIC TRENDS IN U.S. BREAST CANCER MORTALITY Stephanie L. Bailey, PhD, Bronislava Sigal, PhD, Sylvia Plevritis, PhD | ||
| P1-43 | *A NATURAL HISTORY MODEL OF TYPE 2 DIABETES TO EVALUATE TREATMENT GUIDELINES FOR CARDIOVASCULAR RISK MANAGEMENT Murat Kurt, MS, Nilay D. Shah, PhD, Todd R. Huschka, MS, Steven A. Smith, MD, Andrew Schaefer, PhD, Brian T. Denton, PhD | ||
| P1-44 | PERSONAL STORIES IN PUBLICLY AVAILABLE DECISION AIDS Sara D. Khangura, BA, Carol Bennett, MSc, Dawn Stacey, Phd, Annette M. O'Connor, PhD | ||
| P1-45 | PRECEDING BAD WATCHFUL WAITING OUTCOMES CAUSE ANXIETY DURING TREATMENT DECISIONS: A LABORATORY TEST USING A COMPUTER SIMULATED ABDOMINAL AORTIC ANEURYSM PATIENT Joshua Hemmerich, PhD, Elizabeth Ghini, MA, Margaret L. Schwarze, MD, William Dale, MD, PhD | ||
| P1-46 | *DETERMINANTS OF INSURANCE COVERAGE AND RESOURCE UTILIZATION BY THE UNINSURED Aniket A. Kawatkar, B.Pharm, MS, Michael B. Nichol, PhD | ||
| P1-47 | *OVERCOMING EDUCATIONAL BARRIERS FOR ADVANCED CARE PLANNING IN LATINOS WITH VIDEO IMAGES Angelo E. Volandes, MD, Miguel A. Ariza, MD, Elmer D. Abbo, MD, JD, Michael Paasche-Orlow, MD, MA, MPH | ||
| P1-48 | IMPACT OF NONCANCEROUS PELVIC PROBLEMS ON HEALTH-RELATED QUALITY OF LIFE AND PREFERENCES Miriam Kuppermann, PhD, MPH, Lee A. Learman, MD, PhD, Michael Schembri, Steven Gregorich, PhD, Catherine Campbell, A. Eugene Washington, MD | ||
| P1-49 | *COST-EFFECTIVENESS OF HIV MONITORING STRATEGIES IN RESOURCE-LIMITED SETTINGS Eran Bendavid, MD, Am Bayoumi, MD, MSc, David A. Katzenstein, MD, Gillian D. Sanders, PhD, Douglas K. Owens, MD, MS | ||
See more of The 29th Annual Meeting of the Society for Medical Decision Making (October 20-24, 2007)
Papers submitted for the Lee B. Lusted Student Prize Competition are denoted with an asterisk (*)